LUNG: (T-4-20) TH-138
Trial ID
NCT03786692
Trial Sponsor
Fox Chase Cancer Center
A Phase II Randomized Trial of Carboplatin + Pemetrexed + Bevacizumab, With or Without Atezolizumab in Stage IV Non-squamous NSCLC Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked